September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
August 18th 2024
To scale up diabetes intervention programs, sustainable workflows, trainings, and payment models are key.
August 17th 2024
Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.
June 24th 2024
The can’t-miss event on July 13 features speakers and CE sessions focused on streamlining pharmacy finances and services.
April 1st 2024
The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.
Latebreakers: TNF-blocker Humira gets OK for juvenile rheumatoid arthritis
Adalimumab approved for polyarticular juvenile idiopathic arthritis.
Latebreakers: USA Today puts focus on medication errors
USA Today series draws attention to the role of technicians and corporate policies in contributing to medication errors at chain pharmacies.
Pharmacy school offers natural products degree online
Massachusetts College of Pharmacy and Health Sciences offers online degree in natural products, herbals, and dietary supplements.
CMS finds discrepancy between NPI and IRS records
Many business names and identification numbers used in NPI database do not match IRS records, according to the Centers for Medicare & Medicaid Services.
GPO helps hospitals manage use of stents with new toolkit
Premier Inc. offers Rational Choice Rx toolkit to help hospitals manage their patients who are underoing stent placement.
Mental health parity bill passes in the House
The House of Representatives has followed the Senate in passing long-awaited mental health parity legislation.
Medicaid prescription reimbursement information by state - quarter ending December 2007
This table, prepared by the Centers for Medicare & Medicaid Services, lists the reimbursement rates for prescription drugs and dispensing fees by state.
Commonly confused drug pairs
The U.S. Pharmacopeia has developed a new listing of look-alike, soundalike drug names that are often confused, leading to drug errors.
Reports of neuropsychiatric events lead Roche to update Tamiflu warning
Roche updates oseltamivir prescribing information.
Poll finds doctors should still be allowed to prescribe manually
Pharmacists divided over whether Medicare should require e-prescribing.
PhRMA reports lists 547 neurological drugs in development
PhRMA releases report on neurological drugs in development and Hispanics would benefit most from these products.
MinuteClinic hits 500th clinic mark
CVS opens its 500th MinuteClinic location and plans continued expansion
Pharmacy schools train sights on cultural diversity
Two pharmacy schools in California have named new faculty to promote cultural diversity Pharmacy schools train sights on cultural diversity.
Salix partners with Walgreens, CCA to increase awareness of colorectal screenings
Promoting awareness of colon cancer and patient education for March and April.
Pharmacy groups release findings of Project Destiny initiative
Professional groups hope community pharmacy can expand provider role.
Aloxi OK'd for post-op emesis
Palonosetron approved by FDA for postoperative nausea and vomiting.
Aspire36 and Aspire Lite recalled by Palo Alto Labs
Palo Alto Labs recalls Aspire36 and Aspire Lite dietary supplements.
Compounding R.Ph.s demand transparency from FDA over bio-identical hormones
The International Academy of Compounding Pharmacists wants to find out when the Food & Drug Administration became interested in cracking down on the use of estriol for bio-identical hormone replacement therapy.
Congress mulling whether to move human growth hormone to Schedule III
A nonprofit group concerned over short stature in kids opposes legislation now under consideration in Congress that would move human growth hormone into Schedule III of the Controlled Substances Act.
AMA calls on patients to be aware of expired medicines
AMA asks patients if they know what expired medicines are in their homes.
Go-ahead granted for Wyeth's antidepressant Pristiq
Desvenlafaxine is approved by FDA for depression in adults.
New regimen data added to Janumet label
Expanded labeling approved for sitagliptin/metformin.
Baxter recalls all heparin products minus large parenterals
Baxter Healthcare Corp. recalls remaining heparin lots.
Spiriva and Foradil capsules should not be swallowed, warns FDA
FDA advisory on ingestion of tiotropium and formoterol capsules
Abilify granted bipolar indication in new population
Aripiprazole approved for new indication.
NACDS Foundation supports personal medication record to help patients
NACDS Foundation promotes use of a personal medication record to help patients
ADA issues new diet options for diabetics
New recommendations regarding diet represent a departure from the past.
Post-marketing liver injury reports lead to Tysabri PI update
Liver injury warnings added to natalizumab prescribing information.
Pediatric indication granted to Nexium
Esomeprazole approved for children.